Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
400 participants
OBSERVATIONAL
2025-03-15
2025-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does gastric residual volume, content type, and aspiration risk differ between diabetic and non-diabetic patients with similar fasting durations?
Participants undergoing elective surgery will receive bedside gastric ultrasound as part of their preoperative assessment. Ultrasound images will be used to estimate gastric volume and evaluate aspiration risk.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Stomach Fullness and Associated Factors in Elective Surgical Patients
NCT06606782
Gastric Emptying Time After Turkish Breakfast
NCT04789785
Evaluation of the Effect of APFEL Risk Score and Fasting Periods on Postoperative Nausea and/or Vomiting
NCT06022705
Difficult Airway and Ultrasonographic Evaluation
NCT05347121
Preoperative Presence of Gastric Content in Non-fasting Patients - an Ultrasound Study
NCT03685435
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main questions it aims to answer are:
Do diabetic patients have higher residual gastric volume than non-diabetic patients despite similar fasting durations?
Does the type or amount of gastric content differ between the two groups, potentially increasing aspiration risk?
Researchers will compare diabetic and non-diabetic groups to see if diabetes is associated with delayed gastric emptying and increased aspiration risk.
Participants will:
Undergo bedside gastric ultrasound prior to anesthesia induction
Be scanned in semi-sitting and right lateral decubitus positions using a convex ultrasound probe
Have gastric antrum graded and volume calculated
Be evaluated for aspiration risk based on validated ultrasound criteria
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic Group - Patients with a diagnosis of diabetes mellitus Non-Diabetic Group - Patients witho
Diabetic Group Adult patients (aged 18-65) with a known diagnosis of diabetes mellitus who are scheduled for elective surgery under general anesthesia.
These participants will undergo preoperative bedside gastric ultrasound to evaluate residual gastric volume, content type, and aspiration risk.
Non-Diabetic Group Adult patients (aged 18-65) without diabetes mellitus, scheduled for elective surgery under general anesthesia.
These participants will also undergo preoperative bedside gastric ultrasound for the same assessments as the diabetic group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) physical status I -III
* Scheduled for elective surgery under general anesthesia.
* Patients with a known history of diabetes mellitus will be included in the diabetic group.
Exclusion Criteria
* Patients with gastrointestinal obstructive diseases
* Patients with gastroesophageal reflux disease
* History of gastrointestinal surgery
* Emergency surgery cases
* Recent history of abdominal trauma
* Non-diabetic patients with autonomic or neurological disorders
* Patients with chronic kidney disease
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Izmir City Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Derya Arslan Yurtlu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Derya A. Yurtlu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Izmir City Hospital, Izmir, TURKEY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Health Sciences, Izmir Faculty of Medicine, Izmir City Hospital
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IZMIR CITY HOSPİTAL
Identifier Type: OTHER
Identifier Source: secondary_id
IZMIR CITY HOSPİTAL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.